INFUSE BONE GRAFT UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 03,05 report with the FDA on 2015-05-04 for INFUSE BONE GRAFT UNK manufactured by Medtronic Sofamor Danek Usa, Inc.

Event Text Entries

[5885645] It was reported in a publication that a retrospective review of patients with fracture non-unions included in two prospective databases was performed at two us level 1 trauma centers from (b)(6) 1998 (center 1) or (b)(6) 2004 (center 2), respectively, until (b)(6) 2010. A total of 182 patients (102 males and 80 females) met the inclusion criteria. The mean age was 44? 13. 6 years. Sixty-eight patients were confirmed smokers, and 30 patients had a history of smoking and reported cessation prior to nonunion surgery. The remaining 84 patients reported to have never smoked. Patients were stratified into the following cohorts for analysis, based on the bone grafting modality: (1) autograft (n = 105), (2) allograft (n = 38), (3) allograft in combination with autograft (n = 16), and (4) rhbmp-2 with or without adjunctive bone grafting substitute (n = 23). The rhbmp-2 product was mixed with sterile saline and prepared immediately prior to use from a kit containing all necessary components, according to the manufacturer? S instructions. In 6 patients, rhbmp-2 was administered without bone grafting adjunct, while in the remaining 17 patients rhbmp-2 was combined with allograft. The bmp2 cases consisted of 11 tibia, 5 femur, and 7 humerus surgeries. All patients were followed postoperatively for a minimum of 12 months, or until clinical and radiographic bone healing occurred. In the bmp2 cohort, 4 patients required revision bone grafting / non-union.
Patient Sequence No: 1, Text Type: D, B5


[13262538] Article citation: flierl et al. Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: a retrospective cohort study in 182 patients. Journal of orthopaedic surgery and research 2013, 8:33. Patient: mean age 52 yrs (+/- 15). Patient: 7 males, 16 females. Implant date: between (b)(6) 1998 and (b)(6) 2010. (b)(4). Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. Products from multiple manufacturers were implanted during the procedure. Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
Patient Sequence No: 1, Text Type: N, H10


[34305289] (b)(4)
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1030489-2015-00901
MDR Report Key4745573
Report Source03,05
Date Received2015-05-04
Date of Report2015-04-08
Date of Event2013-09-09
Date Mfgr Received2015-04-08
Date Added to Maude2015-05-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactHUZEFA MAMOOLA
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal Code38132
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT
Generic NameFILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD, OSTEOIN
Product CodeMPW
Date Received2015-05-04
Model NumberNA
Catalog NumberUNK
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Address4340 SWINEA RD MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2015-05-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.